-
Salvianolate ameliorates renal tubular injury through the Keap1/Nrf2/ARE pathway in mouse kidney ischemia-reperfusion injury
Product used: EZ cell transfection reagentJournal of EthnopharmacologyDetails -
Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells
Product used: EZ ECL pico chemiluminescent liquid (super sensitive)Signal Transduction and Targeted TherapyDetails -
ZLN005 alleviates in vivo and in vitro renal fibrosis via PGC-1α-mediated mitochondrial homeostasis
Product used: EZ Trans cell transfection reagent (efficient)PharmaceuticalsDetails -
CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in …
Product used: EZ ECL pico chemiluminescent liquid (super sensitive)International ImmunopharmacologyDetails -
Novel diagnostic biomarkers of oxidative stress, immune-infiltration characteristics and experimental validation of SERPINE1 in colon cancer
Product used: Quick sealing solution (ready to use, wash free)Hormones and CancerDetails -
CXCL5 Promotes Acetaminophen-Induced Hepatotoxicity by Activating Kupffer Cells
Product used: PBS bufferInternational Journal of Molecular SciencesDetails -
CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells
Product used: EZ cell transfection reagentInternational Journal of OncologyDetails -
Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
Product used: Universal tissue cell fixative (4% paraformaldehyde)PharmaceuticalsDetails -
Exploring the application of sildenafil for high-fat diet-induced erectile dysfunction based on interleukin-18-mediated NLRP3/Caspase-1 signaling pathway
Product used: EZ cell transfection reagentSexual MedicineDetails -
Low‑dose ionizing radiation attenuates high glucose‑induced hepatic apoptosis and immune factor release via modulation of a miR‑155‑SOCS1 axis
Product used: EZ ECL Chemiluminescence Liquid (Enhanced)Molecular Medicine ReportsDetails
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands